The effect of Tabex (cytisine) on success of attempts to stop smoking

促进戒烟可能是减少癌症的唯一最重要的目标。有几种药物可以有所帮助，心理支持也很有效。是否有机会评估一种已经在东欧使用多年的药物（Tabex），它是通用的且生产成本低廉？如此之多，以至于它的成本不到目前药物的五分之一。这对英国的吸烟者、英国国家医疗服务体系（NHS），或许更重要的是对海外的低收入吸烟者来说，将是相当有益的。拟议的严格审判将在波兰进行，将非常物有所值。研究结果将通过与MHRA和其他相关监管机构的讨论来推进，以建立许可的基础。一旦一篇论文在适当的同行审查期刊上受到惩罚，研究结果也将通过适当的新闻办公室传播。

Promoting smoking cessation is probably the single most important goal in reducing cancer. There are several drugs that can help, and psychological support is also effective. There is an opportunity to evaluate a drug (Tabex) that has been in use in Eastern Europe for many years, is generic and cheap to manufacture ? so much so that it costs less than one fifth of current medications. This would be of considerable benefit to UK smokers, the NHS and perhaps more importantly to low income smokers overseas. The proposed rigorous trial would be conducted in Poland and would represent exceptional value for money.The findings will be taken forward through discussion with the MHRA and other relevant regulatory bodies to establish a basis for licensing. The results will also be dissemintated through appropriate press offices once a paper has been punlished in an appropriate peer review journal.